# Novo Nordisk A/S – FDA Inspection, May 4, 2023

Source: https://www.keypedia.com/records/fda_inspections/novo-nordisk-as/66074870-de76-43e2-b8fd-c93d30311f61
Source feed: FDA_Inspections

> FDA inspection 1209127 of Novo Nordisk A/S, May 04, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1209127
- Company Name: Novo Nordisk A/S
- Inspection Date: 2023-05-04
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1269488 - 2024-03-25](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as/06fe2bd0-d7e0-4521-9fdf-92aaf736552d)
- FDA Inspection 1230597 - 2022-12-02
- FDA Inspection 1107225 - 2019-09-06
- FDA Inspection 1044502 - 2018-03-07
- FDA Inspection 1028554 - 2017-08-29

## Related Officers

- Mikhail V. Ovanesov
- [FDA Associated Person](https://www.keypedia.com/people/prabhu-p-raju/2c0aaede-fe16-4431-bc21-614d7f18cb32)
- [FDA Associated Person](https://www.keypedia.com/people/unnee-ranjan/43f1d07e-4079-4d33-88a9-baf6a5df932c)

Company: https://www.keypedia.com/companies/novo-nordisk-as/b48359f1-0bb7-4fff-80dd-688aab40951b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
